Suppr超能文献

Grb2 衔接蛋白在核磷蛋白-间变性淋巴瘤激酶(NPM-ALK)介导的信号转导和间变大细胞淋巴瘤生长中的作用。

Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth.

机构信息

Center for Experimental Research and Medical Studies, University of Torino, Torino, Italy.

出版信息

J Biol Chem. 2010 Aug 20;285(34):26441-50. doi: 10.1074/jbc.M110.116327. Epub 2010 Jun 16.

Abstract

Most anaplastic large cell lymphomas (ALCL) express oncogenic fusion proteins derived from chromosomal translocations or inversions of the anaplastic lymphoma kinase (ALK) gene. Frequently ALCL carry the t(2;5) translocation, which fuses the ALK gene to the nucleophosmin (NPM1) gene. The transforming activity mediated by NPM-ALK fusion induces different pathways that control proliferation and survival of lymphoma cells. Grb2 is an adaptor protein thought to play an important role in ALK-mediated transformation, but its interaction with NPM-ALK, as well as its function in regulating ALCL signaling pathways and cell growth, has never been elucidated. Here we show that active NPM-ALK, but not a kinase-dead mutant, bound and induced Grb2 phosphorylation in tyrosine 160. An intact SH3 domain at the C terminus of Grb2 was required for Tyr(160) phosphorylation. Furthermore, Grb2 did not bind to a single region but rather to different regions of NPM-ALK, mainly Tyr(152-156), Tyr(567), and a proline-rich region, Pro(415-417). Finally, shRNA knockdown experiments showed that Grb2 regulates primarily the NPM-ALK-mediated phosphorylation of SHP2 and plays a key role in ALCL cell growth.

摘要

大多数间变性大细胞淋巴瘤(ALCL)表达源自间变性淋巴瘤激酶(ALK)基因的染色体易位或倒位的致癌融合蛋白。ALCL 通常携带 t(2;5)易位,该易位将 ALK 基因与核仁磷酸蛋白(NPM1)基因融合。NPM-ALK 融合介导的转化活性诱导控制淋巴瘤细胞增殖和存活的不同途径。Grb2 是一种衔接蛋白,被认为在 ALK 介导的转化中发挥重要作用,但它与 NPM-ALK 的相互作用以及在调节 ALCL 信号通路和细胞生长中的功能从未被阐明。在这里,我们表明,活性 NPM-ALK,但不是激酶失活突变体,结合并诱导 Grb2 在酪氨酸 160 处磷酸化。Grb2 的 C 末端完整的 SH3 结构域是 Tyr(160)磷酸化所必需的。此外,Grb2 不是结合到单个区域,而是结合到 NPM-ALK 的不同区域,主要是 Tyr(152-156)、Tyr(567)和富含脯氨酸的区域 Pro(415-417)。最后,shRNA 敲低实验表明,Grb2 主要调节 NPM-ALK 介导的 SHP2 磷酸化,并在 ALCL 细胞生长中发挥关键作用。

相似文献

3
Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target.
Blood. 2017 Feb 16;129(7):823-831. doi: 10.1182/blood-2016-05-717793. Epub 2016 Nov 22.
5
p130Cas mediates the transforming properties of the anaplastic lymphoma kinase.
Blood. 2005 Dec 1;106(12):3907-16. doi: 10.1182/blood-2005-03-1204. Epub 2005 Aug 16.
6
Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency.
Oncogene. 2016 Jul 21;35(29):3854-3865. doi: 10.1038/onc.2015.456. Epub 2015 Dec 14.

引用本文的文献

1
Shc1 cooperates with Frs2 and Shp2 to recruit Grb2 in FGF-induced lens development.
Elife. 2025 May 6;13:RP103615. doi: 10.7554/eLife.103615.
2
ALK in cancer: from function to therapeutic targeting.
Nat Rev Cancer. 2025 May;25(5):359-378. doi: 10.1038/s41568-025-00797-9. Epub 2025 Mar 7.
3
Shc1 cooperates with Frs2 and Shp2 to recruit Grb2 in FGF-induced lens development.
bioRxiv. 2025 Feb 17:2024.10.20.619055. doi: 10.1101/2024.10.20.619055.
4
The Configuration of GRB2 in Protein Interaction and Signal Transduction.
Biomolecules. 2024 Feb 22;14(3):259. doi: 10.3390/biom14030259.
5
Defining Pathological Activities of ALK in Neuroblastoma, a Neural Crest-Derived Cancer.
Int J Mol Sci. 2021 Oct 29;22(21):11718. doi: 10.3390/ijms222111718.
6
Aberrant role of ALK in tau proteinopathy through autophagosomal dysregulation.
Mol Psychiatry. 2021 Oct;26(10):5542-5556. doi: 10.1038/s41380-020-01003-y. Epub 2021 Jan 15.
7
A novel model of controlling PD-L1 expression in ALK anaplastic large cell lymphoma revealed by CRISPR screening.
Blood. 2019 Jul 11;134(2):171-185. doi: 10.1182/blood.2019001043. Epub 2019 May 31.
10
Grb2 monomer-dimer equilibrium determines normal versus oncogenic function.
Nat Commun. 2015 Jun 24;6:7354. doi: 10.1038/ncomms8354.

本文引用的文献

3
Activating mutations in ALK provide a therapeutic target in neuroblastoma.
Nature. 2008 Oct 16;455(7215):975-8. doi: 10.1038/nature07397.
5
Roles for deregulated receptor tyrosine kinases and their downstream signaling molecules in hematologic malignancies.
Cancer Sci. 2008 Mar;99(3):479-85. doi: 10.1111/j.1349-7006.2007.00717.x. Epub 2008 Jan 2.
6
The anaplastic lymphoma kinase in the pathogenesis of cancer.
Nat Rev Cancer. 2008 Jan;8(1):11-23. doi: 10.1038/nrc2291.
7
Pathobiology of ALK+ anaplastic large-cell lymphoma.
Blood. 2007 Oct 1;110(7):2259-67. doi: 10.1182/blood-2007-04-060715. Epub 2007 May 22.
9
Molecular targeting of growth factor receptor-bound 2 (Grb2) as an anti-cancer strategy.
Anticancer Drugs. 2006 Jan;17(1):13-20. doi: 10.1097/01.cad.0000185180.72604.ac.
10
Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells.
Blood. 2006 Feb 15;107(4):1617-23. doi: 10.1182/blood-2005-08-3254. Epub 2005 Oct 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验